1155 Activated regulatory T cells in solid tumors express CD30, which are selectively targeted by the novel anti-CD30 antibody drug conjugate SGN-35T

• Hailing Lu,
• Brian P O’Connor,
• Ryan A Heiser,
• Jason D Berndt,
• Michelle L Ulrich,
• Bryan M Grogan,
• Reice D James,
• Melissa Conerly,
• Astrid Clarke,
• Kevin J Hamblett

Affiliations

Hailing Lu

Aff1 grid.34477.330000000122986657Department of MedicineUniversity of Washington Seattle WA USA

Brian P O’Connor

Center for Genes, Environment, & Health, National Jewish Health, Denver, Colorado, USA

Ryan A Heiser

Seagen, Bothell, WA, USA

Jason D Berndt

12Seagen Inc., Bothell, WA, USA

Michelle L Ulrich

1Seagen Inc., Bothell, WA, USA

Bryan M Grogan

Seagen, Inc., Bothell, WA, USA

Reice D James

Seagen, Inc., Bothell, WA, USA

Melissa Conerly

Seagen, Inc., Bothell, WA, USA

Astrid Clarke

Seagen, Inc., Bothell, WA, USA

Kevin J Hamblett

Seagen, Inc., Bothell, WA, USA